167 related articles for article (PubMed ID: 22040631)
21. The association between gastroesophageal reflux disease and obesity.
Friedenberg FK; Xanthopoulos M; Foster GD; Richter JE
Am J Gastroenterol; 2008 Aug; 103(8):2111-22. PubMed ID: 18796104
[TBL] [Abstract][Full Text] [Related]
22. Bariatric Surgery and the Mechanisms of Gastroesophageal Reflux Disease.
Nedelcu M; Noel P; Loureiro M; Palermo M; Nedelcu A; Nocca D
J Laparoendosc Adv Surg Tech A; 2020 Aug; 30(8):907-911. PubMed ID: 32614705
[No Abstract] [Full Text] [Related]
23. Surgical management of gastroesophageal reflux disease in obesity.
Ikramuddin S
Dig Dis Sci; 2008 Sep; 53(9):2318-29. PubMed ID: 18663575
[TBL] [Abstract][Full Text] [Related]
24. Gastroesophageal Reflux Disease in Obese Patients.
Valezi AC; Herbella FAM; Schlottmann F; Patti MG
J Laparoendosc Adv Surg Tech A; 2018 Aug; 28(8):949-952. PubMed ID: 30004267
[TBL] [Abstract][Full Text] [Related]
25. Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease.
Varela JE; Hinojosa MW; Nguyen NT
Surg Obes Relat Dis; 2009; 5(2):139-43. PubMed ID: 18996768
[TBL] [Abstract][Full Text] [Related]
26. Antireflux operation for gastroesophageal reflux after Roux-en-y gastric bypass for obesity.
Chen RH; Lautz D; Gilbert RJ; Bueno R
Ann Thorac Surg; 2005 Nov; 80(5):1938-40. PubMed ID: 16242496
[TBL] [Abstract][Full Text] [Related]
27. [Obesity and gastroesophageal reflux disease].
Gómez Escudero O; Herrera Hernández MF; Valdovinos Díaz MA
Rev Invest Clin; 2002; 54(4):320-7. PubMed ID: 12415956
[TBL] [Abstract][Full Text] [Related]
28. Surgeon experience with insurance barriers to offering gastric bypass as an evidence-based operation for pathologic GERD.
Ibele AR; Nau PN; Galvani C; Roth JS; Goldberg RF; Kurian MS; Khaitan L; Gould J; Pandya YK;
Surg Endosc; 2023 Oct; 37(10):7642-7648. PubMed ID: 37491660
[TBL] [Abstract][Full Text] [Related]
29. Roux-en-Y gastric bypass in a patient with morphea.
Lomas S; Forgione P
Surg Obes Relat Dis; 2013; 9(6):e89-90. PubMed ID: 22326279
[No Abstract] [Full Text] [Related]
30. Acid suppression medications are associated with suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass in patients older than 40 years.
Ward EK; Jensen-Otsu E; Schoen JA; Rothchild K; Mitchell B; Austin GL
Surg Obes Relat Dis; 2015; 11(3):585-90. PubMed ID: 25553887
[TBL] [Abstract][Full Text] [Related]
31. The effect of bariatric surgery on gastroesophageal reflux disease.
El-Hadi M; Birch DW; Gill RS; Karmali S
Can J Surg; 2014 Apr; 57(2):139-44. PubMed ID: 24666452
[TBL] [Abstract][Full Text] [Related]
32. Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease.
De Groot NL; Burgerhart JS; Van De Meeberg PC; de Vries DR; Smout AJ; Siersema PD
Aliment Pharmacol Ther; 2009 Dec; 30(11-12):1091-102. PubMed ID: 19758397
[TBL] [Abstract][Full Text] [Related]
33. Outcome of esophageal function and 24-hour esophageal pH monitoring after vertical banded gastroplasty and Roux-en-Y gastric bypass.
Ortega J; Escudero MD; Mora F; Sala C; Flor B; Martinez-Valls J; Sanchiz V; Martinez-Alzamora N; Benages A; Lledo S
Obes Surg; 2004 Sep; 14(8):1086-94. PubMed ID: 15479598
[TBL] [Abstract][Full Text] [Related]
34. Impact of preoperative wireless pH monitoring in the evaluation of esophageal conditions prior to bariatric surgery in a severely obese patient population.
Melendez-Rosado J; Gutierrez-Blanco D; Schneider A; Menzo EL; Szomstein S; Rosenthal RJ
Surg Obes Relat Dis; 2019 Feb; 15(2):288-294. PubMed ID: 30642753
[TBL] [Abstract][Full Text] [Related]
35. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass.
Kellogg TA; Andrade R; Maddaus M; Slusarek B; Buchwald H; Ikramuddin S
Surg Obes Relat Dis; 2007; 3(1):52-7; discussion 58-9. PubMed ID: 17116426
[TBL] [Abstract][Full Text] [Related]
36. Is Roux-en-Y gastric bypass safe after previous antireflux surgery? Technical feasibility and postoperative symptom assessment.
Houghton SG; Nelson LG; Swain JM; Nesset EM; Kendrick ML; Thompson GB; Murr MM; Nichols FC; Sarr MG
Surg Obes Relat Dis; 2005; 1(5):475-80. PubMed ID: 16925273
[TBL] [Abstract][Full Text] [Related]
37. GERD outcome after bariatric surgery: A protocol for systematic review and meta analysis.
Elzouki AN; Waheed MA; Suwileh S; Adoor DM; Tashani O; Abou Samra AB
Medicine (Baltimore); 2020 May; 99(19):e19823. PubMed ID: 32384427
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Endoscopic Bariatric and Metabolic Therapies on Gastroesophageal Reflux Disease.
Kim SY
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440943
[TBL] [Abstract][Full Text] [Related]
39. Complete regression of Barrett's esophagus after Roux-en-Y gastric bypass.
Cobey F; Oelschlager B
Obes Surg; 2005 May; 15(5):710-2. PubMed ID: 15946466
[TBL] [Abstract][Full Text] [Related]
40. Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or hiatal hernia.
Soricelli E; Iossa A; Casella G; Abbatini F; Calì B; Basso N
Surg Obes Relat Dis; 2013; 9(3):356-61. PubMed ID: 22867558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
